Skip to content

Clinical trials

Glomerulonephritis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis Country / region: Canada Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20171
20202
20212
20221
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Recruiting3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
University Health Network, Toronto2
Alexion Pharmaceuticals, Inc.1
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Human Genome Sciences Inc., a GSK Company1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Swedish Orphan Biovitrum1
The George Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis12
Glomerulonephritis, IGA8
Kidney Diseases7
Renal Insufficiency, Chronic4
Autoimmune Diseases3
Nephritis3
Urologic Diseases3
Immune System Diseases2
Lupus Nephritis2
Female Urogenital Diseases1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.